AC Immune is a biopharmaceutical company focused on neurodegenerative diseases with three product candidates in clinical trials
AC Immune was founded in 2003 by Andrea Pfeifer.
1282 health care and life sciences companies are in the directory, 159 of them in the same 51-100 employee range and 131 based in Europe.
Takeda has entered into a $2.2 billion deal with AC Immune for an Alzheimer's therapy. Individual investors own 24% of AC Immune shares, while private equity firms control 30% of the company.
“AC Immune SA, a global leader in developing precision medicine for neurodegenerative diseases (incl. Alzheimer & Parkinson's) with cutting-edge technology platforms” acimmune.com
Founded in 2003, AC Immune works in biotechnology, pharmaceutical and therapeutics from Europe and has 51-100 employees. It has raised $167.5 million over 5 rounds and its website drew about 3,538 visits in the latest month measured.
101-250 employees · aveooncology.com
101-250 employees · aclaristx.com
11-50 employees · advancells.com
1-10 employees · 101therapeutics.com
1-10 employees · abbiosciences.com
51-100 employees · aoporphan.com
51-100 employees · acrivon.com
51-100 employees · 4basebio.com
51-100 employees · 4sc.de
51-100 employees · adocia.com
Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.